Log in to save to my catalogue

The noncanonical role of EZH2 in cancer

The noncanonical role of EZH2 in cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8019201

The noncanonical role of EZH2 in cancer

About this item

Full title

The noncanonical role of EZH2 in cancer

Publisher

England: John Wiley & Sons, Inc

Journal title

Cancer science, 2021-04, Vol.112 (4), p.1376-1382

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Enhancer of zeste homolog 2 (EZH2) is the catalytic subunit of polycomb repressive complex 2 (PRC2). Dysregulation of EZH2 causes alteration of gene expression and functions, thereby promoting cancer development. The regulatory function of EZH2 varies across different tumor types. The canonical role of EZH2 is gene silencing through catalyzing the...

Alternative Titles

Full title

The noncanonical role of EZH2 in cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8019201

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8019201

Other Identifiers

ISSN

1347-9032,1349-7006

E-ISSN

1349-7006

DOI

10.1111/cas.14840

How to access this item